세계의 바이러스 클리어런스 서비스 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Viral Clearance Service Market is presumed to reach the market size of nearly USD 3030.49 Million by 2032 from USD 858.09 Million in 2023 with a CAGR of 15.05% under the study period 2024 - 2032.

Viral clearance service refers to a process conducted by biopharmaceutical companies to ensure the safety of biological products by removing or inactivating viruses and other potential contaminants. This service involves rigorous testing and validation procedures to demonstrate the effectiveness of viral clearance methods such as chromatography, filtration, and inactivation techniques. Viral clearance services are critical in developing and manufacturing biologics, vaccines, and gene therapy products to mitigate the risk of viral transmission to patients.

MARKET DYNAMICS

The increasing prevalence of viral infections, outbreaks, and emerging pathogens, coupled with the growing need for biopharmaceutical products, including monoclonal antibodies, monoclonaland recombinant proteins, has heightened the need for robust viral clearance validation research to guarantee the safety and efficacy of biopharmaceutical products for human use. Viral clearance services play a critical role in assessing the viral safety of biologics by evaluating the effectiveness of viral inactivation and removal steps during manufacturing processes, driving their adoption across the biopharmaceutical industry. Additionally, stringent regulatory requirements and guidelines issued by health authorities such as the EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) mandate the implementation of viral clearance studies as part of the regulatory approval process for biopharmaceutical products, driving market demand. Moreover, increasing complexity and diversity in biopharmaceutical production processes, including cell culture, fermentation, and purification, have created challenges in effectively addressing viral contamination risks, driving the need for specialized expertise and testing services offered by viral clearance service providers, further fuelling market growth.

Furthermore, the growing trend towards outsourcing viral clearance testing and validation studies by biopharmaceutical companies, driven by resource constraints, time-to-market pressures, and the need for independent third-party validation, has created opportunities for contract research organizations (CROs) and testing laboratories to offer comprehensive viral clearance services, driving market expansion. The evolving landscape of viral safety regulations, advancements in analytical techniques, and emerging trends in bioprocessing technology are expected to drive further innovation and investment in the market, supporting the development and commercialization of safe and effective biopharmaceutical products for global healthcare markets. However, evolving regulatory requirements, technological advancements, and competition from in-house viral clearance capabilities may challenge the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of viral clearance service. The growth and trends of viral clearance service industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the viral clearance service market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

• Viral Removal
• Viral Inactivation (Chemical, Radiation, Others)

By Application

• Recombinant Proteins
• Tissue And Blood-Derived Products
• Vaccines
• Others

By End-User

• Biopharmaceuticals
• Contract Research Organizations
• Academic Research Institutes
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Viral Clearance Service market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Viral Clearance Service market include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA, WuXi AppTec, Clean Cells, Vironova Biosafety AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . VIRAL CLEARANCE SERVICE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Method
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY METHOD

• 5.1 Overview by Method
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Method
• 5.4 Viral Removal Historic and Forecast Sales by Regions
• 5.5 Viral Inactivation (Chemical, Radiation, Others) Historic and Forecast Sales by Regions

6 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Recombinant Proteins Historic and Forecast Sales by Regions
• 6.5 Tissue and Blood-derived Products Historic and Forecast Sales by Regions
• 6.6 Vaccines Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY END-USER

• 7.1 Overview by End-user
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-user
• 7.4 Biopharmaceuticals Historic and Forecast Sales by Regions
• 7.5 Contract Research Organizations Historic and Forecast Sales by Regions
• 7.6 Academic Research Institutes Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL VIRAL CLEARANCE SERVICE MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE VIRAL CLEARANCE SERVICE COMPANIES

• 9.1. Viral Clearance Service Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF VIRAL CLEARANCE SERVICE INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Texcell
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Eurofins Scientific SE
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Charles River Laboratories International Inc.
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Merck KGaA
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. WuXi AppTec
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Clean Cells
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Vironova Biosafety AB
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies